ResMed

RMD NYSE
Overview Stats Financials News

Yahoo Finance • 18 days ago

MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data Access

MatrixCare The alliance with Health Gorilla will provide MatrixCare customers with more than 220 million patient records to streamline workflows and improve patient outcomes. BLOOMINGTON, Minn., May 16, 2024 (GLOBE NEWSWIRE) -- MatrixCar... Full story

Yahoo Finance • a month ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Sector Update: Health Care Stocks Edge Higher Late Afternoon... Full story

Yahoo Finance • a month ago

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024

ResMed Inc. Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23% Operating cash flows of $402 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://in... Full story

Yahoo Finance • 4 months ago

ResMed CEO: Weight-Loss Drugs Aren’t Cutting Demand for Sleep Apnea Treatment

As excitement built last year over weight-loss drugs from Novo Nordisk and Eli Lilly investors abandoned companies that treat disorders inflamed by obesity. Shares of ResMed sank 40% from July to October, on fears that fewer people would s... Full story

Yahoo Finance • 4 months ago

Q2 2024 Resmed Inc Earnings Call

Participants Amy Wakeham; Chief IR Officer; ResMed Inc. Brett A. Sandercock; CFO; ResMed Inc. Michael J. Farrell; CEO & Chairman; ResMed Inc. Anthony Charles Petrone; MD & Senior Medical Devices, Diagnostics and Therapeutics Equity Res... Full story

Yahoo Finance • 5 months ago

ResMed says its masks to remain on market despite FDA classification

Jan 16 (Reuters) - ResMed said its respiratory masks containing magnets will remain on the market even though the U.S. Food and Drug Administration classified a recall of the product as most serious as their use could cause major injuries... Full story

Yahoo Finance • 5 months ago

ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference

ResMed Inc. SAN DIEGO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer and chair of the board, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monda... Full story

Yahoo Finance • 6 months ago

ResMed Secures Significant Victory in Patent Fight Against New York University

ResMed Inc. SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) announced that it has secured a significant victory after the United States Patent Trial and Appeals Board (PTAB) invalidated the claims New York Univer... Full story

Yahoo Finance • 7 months ago

ResMed Inc's Dividend Analysis

Assessing the Sustainability and Growth of ResMed Inc's Dividend ResMed Inc(NYSE:RMD) recently announced a dividend of $0.48 per share, payable on 2023-12-14, with the ex-dividend date set for 2023-11-08. As investors look forward to this... Full story

Yahoo Finance • 7 months ago

2 Monster Stocks to Buy Without Any Hesitation

First, consumer health juggernaut Kenvue (NYSE: KVUE) produces and markets seven No. 1 global brands. Meanwhile, ResMed (NYSE: RMD), a leader in continuous positive airway pressure (CPAP) machines, has delivered enormous total returns of o... Full story

Yahoo Finance • 8 months ago

ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023

ResMed Inc. SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2024 on Thursday, October 26, 2023, after the... Full story

Yahoo Finance • a year ago

ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023

ResMed Inc. SAN DIEGO, July 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2023 on Thursday, August 3, 2023, after the... Full story

Yahoo Finance • a year ago

ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 74% of the company

Key Insights Given the large stake in the stock by institutions, ResMed's stock price might be vulnerable to their trading decisions The top 18 shareholders own 50% of the company Recent sales by insiders A look at the shareholders of Re... Full story

Yahoo Finance • a year ago

Sleep-Apnea Growth Stock Breaks Out On Record Earnings; Device Sales Surge

Growth stock and sleep-apnea device maker ResMed broke out Friday after quarterly earnings continued to accelerate. Shares surged above an entry at 227.94 from a cup with handle in strong volume and are in a buy zone, according to IBD Mark... Full story

Yahoo Finance • a year ago

3 Incredible Growth Stocks to Buy Right Now

U.S. stock markets are going through an unusually volatile period, thanks to the uncertainty posed by the global banking crisis and the Federal Reserve's plan for interest rates. While wild price swings can be nerve-racking for shareholder... Full story

Yahoo Finance • a year ago

ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum

ResMed Inc. SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life Sciences & MedTech Investor Foru... Full story

Yahoo Finance • a year ago

ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference

ResMed Inc. SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 33rd Annual Healthcare Conference on Monday, March... Full story

Yahoo Finance • 2 years ago

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023

Year-over-year revenue grows 5%, operating profit up 5%, non-GAAP operating profit up 4% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 27, 2022 (GLOBE... Full story

Yahoo Finance • 2 years ago

ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022

ResMed Inc. SAN DIEGO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2023 on Thursday, October 27, 2022, after the... Full story

Yahoo Finance • 2 years ago

Investors Shouldn't Overlook ResMed's (NYSE:RMD) Impressive Returns On Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that ca... Full story